{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:54:31Z","timestamp":1759179271415},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1038\/s41390-020-01153-3","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T18:18:38Z","timestamp":1600193918000},"page":"1780-1787","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MicroRNA in dried blood spots from patients with Aagenaes syndrome and evaluation of pre-analytical and analytical factors"],"prefix":"10.1038","volume":"89","author":[{"given":"Monica","family":"Atneosen-\u00c5segg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Melheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runar","family":"Almaas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"1153_CR1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/ijms19010261","volume":"16","author":"F Schueller","year":"2018","unstructured":"Schueller, F. et al. The role of miRNAs in the pathophysiology of liver diseases and toxicity. Int. J. Mol. Sci. 16, 261 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"1153_CR2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56630-5","volume":"10","author":"J Cisilotto","year":"2020","unstructured":"Cisilotto, J. et al. MicroRNA profiles in serum samples from acute-on-chronic liver failure patients and miR-25-3p as a potential biomarker for survival prediction. Sci. Rep. 10, 100 (2020).","journal-title":"Sci. Rep."},{"key":"1153_CR3","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.2147\/DMSO.S231321","volume":"12","author":"OM Hendy","year":"2019","unstructured":"Hendy, O. M. et al. The circulating micro-RNAs (-122, -34a and -99a) as predictive biomarkers for non-alcoholic fatty liver diseases. Diabetes Metab. Syndr. Obes. 12, 2715\u20132723 (2019).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"1153_CR4","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/hep.30572","volume":"69","author":"P Starlinger","year":"2019","unstructured":"Starlinger, P. et al. Predicting postoperative liver dysfunction based on blood-derived microRNA signatures. Hepatology 69, 2636\u20132651 (2019).","journal-title":"Hepatology"},{"key":"1153_CR5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/hep.28786","volume":"65","author":"A Shaked","year":"2017","unstructured":"Shaked, A. et al. An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection. Hepatology 65, 269\u2013280 (2017).","journal-title":"Hepatology"},{"key":"1153_CR6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.21037\/atm.2019.08.72","volume":"7","author":"Y Ouyang","year":"2019","unstructured":"Ouyang, Y., Fu, X., Peng, S., Tan, D. & Fu, L. Plasma miR-146a predicts serological conversion of hepatitis B e-antigen (HBeAg) in chronic hepatitis B patients treated with nucleotide analogs. Ann. Transl. Med. 7, 449 (2019).","journal-title":"Ann. Transl. Med."},{"key":"1153_CR7","doi-asserted-by":"crossref","first-page":"E409","DOI":"10.3390\/cancers11030409","volume":"11","author":"I Crist\u00f3bal","year":"2019","unstructured":"Crist\u00f3bal, I. et al. The role of microRNAs in hepatoblastoma tumors. Cancers 11, E409 (2019).","journal-title":"Cancers"},{"key":"1153_CR8","doi-asserted-by":"publisher","unstructured":"Pan, W. M. et al. miR-210 participates in hepatic ischemia reperfusion injury by forming a negative feedback loop with SMAD4. Hepatology https:\/\/doi.org\/10.1002\/hep.31221 (2020).","DOI":"10.1002\/hep.31221"},{"key":"1153_CR9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1940-6207.CAPR-11-0370","volume":"5","author":"CC Pritchard","year":"2012","unstructured":"Pritchard, C. C. et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev. Res. 5, 492\u2013497 (2012).","journal-title":"Cancer Prev. Res."},{"key":"1153_CR10","first-page":"94","volume":"4","author":"MB Kirschner","year":"2013","unstructured":"Kirschner, M. B. et al. The impact of hemolysis on cell-free microRNA biomarkers. Front. Genet. 4, 94 (2013).","journal-title":"Front. Genet."},{"key":"1153_CR11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1373\/clinchem.2010.157198","volume":"57","author":"JS McDonald","year":"2011","unstructured":"McDonald, J. S., Milosevic, D., Reddi, H. V., Grebe, S. K. & Algeciras-Schimnich, A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin. Chem. 57, 833\u2013840 (2011).","journal-title":"Clin. Chem."},{"key":"1153_CR12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/10408363.2018.1561641","volume":"56","author":"C Diener","year":"2019","unstructured":"Diener, C., Galata, V., Keller, K. & Meese, E. MicroRNA profiling from dried blood samples. Crit. Rev. Clin. Lab. Sci. 56, 111\u2013117 (2019).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"1153_CR13","doi-asserted-by":"crossref","first-page":"E2552","DOI":"10.3390\/ijms18122552","volume":"18","author":"P Rodil-Garcia","year":"2017","unstructured":"Rodil-Garcia, P., Arellanes-Licea, E. D. C. & Salazar-Olivo, L. A. Analysis of microRNA Expression in newborns with differential birth weight using newborn screening cards. Int. J. Mol. Sci. 18, E2552 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"1153_CR14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/pr.2015.276","volume":"79","author":"V Ponnusamy","year":"2016","unstructured":"Ponnusamy, V. et al. A study of microRNAs from dried blood spots in newborns after perinatal asphyxia: a simple and feasible biosampling method. Pediatr. Res. 79, 799\u2013805 (2016).","journal-title":"Pediatr. Res."},{"key":"1153_CR15","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1373\/clinchem.2017.271619","volume":"63","author":"M Kahraman","year":"2017","unstructured":"Kahraman, M. et al. Technical stability and biological variability in microRNAs from dried blood spots: a lung cancer therapy-monitoring showcase. Clin. Chem. 63, 1476\u20131488 (2017).","journal-title":"Clin. Chem."},{"key":"1153_CR16","doi-asserted-by":"crossref","first-page":"e0167969","DOI":"10.1371\/journal.pone.0167969","volume":"12","author":"C Glinge","year":"2017","unstructured":"Glinge, C. et al. Stability of circulating blood-based MicroRNAs - pre-analytic methodological considerations. PLoS ONE 12, e0167969 (2017).","journal-title":"PLoS ONE"},{"key":"1153_CR17","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1158\/1055-9965.EPI-14-0550","volume":"23","author":"H Zhao","year":"2014","unstructured":"Zhao, H. et al. Effects of preanalytic variables on circulating microRNAs in whole blood. Cancer Epidemiol. Biomarkers Prev. 23, 2643\u20132648 (2014).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1153_CR18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1373\/clinchem.2015.247668","volume":"62","author":"RS George","year":"2016","unstructured":"George, R. S. & Moat, S. J. Effect of dried blood spot quality on newborn screening analyte concentrations and recommendations for minimum acceptance criteria for sample analysis. Clin. Chem. 62, 466\u2013475 (2016).","journal-title":"Clin. Chem."},{"key":"1153_CR19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2006.04.013","volume":"373","author":"M Holub","year":"2006","unstructured":"Holub, M. et al. Influence of hematocrit and localisation of punch in dried blood spots on levels of amino acids and acylcarnitines measured by tandem mass spectrometry. Clin. Chim. Acta 373, 27\u201331 (2006).","journal-title":"Clin. Chim. Acta"},{"key":"1153_CR20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/adc.43.232.646","volume":"43","author":"O Aagenaes","year":"1968","unstructured":"Aagenaes, O., van der Hagen, C. B. & Refsum, S. Hereditary recurrent intrahepatic cholestasis from birth. Arch. Dis. Child. 43, 646\u2013657 (1968).","journal-title":"Arch. Dis. Child."},{"key":"1153_CR21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/00365520500335183","volume":"41","author":"M Drivdal","year":"2006","unstructured":"Drivdal, M., Trydal, T., Hagve, T. A., Bergstad, I. & Aagenaes, O. Prognosis, with evaluation of general biochemistry, of liver disease in lymphoedema cholestasis syndrome 1 (LCS1\/Aagenaes syndrome). Scand. J. Gastroenterol. 41, 465\u2013471 (2006).","journal-title":"Scand. J. Gastroenterol."},{"key":"1153_CR22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/00365529850170955","volume":"33","author":"O Aagenaes","year":"1998","unstructured":"Aagenaes, O. Hereditary cholestasis with lymphoedema (Aagenaes syndrome, cholestasis-lymphoedema syndrome). New cases and follow-up from infancy to adult age. Scand. J. Gastroenterol. 33, 335\u2013345 (1998).","journal-title":"Scand. J. Gastroenterol."},{"key":"1153_CR23","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1086\/303080","volume":"67","author":"LN Bull","year":"2000","unstructured":"Bull, L. N. et al. Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q. Am. J. Hum. Genet. 67, 994\u2013999 (2000).","journal-title":"Am. J. Hum. Genet."},{"key":"1153_CR24","doi-asserted-by":"publisher","unstructured":"Bj\u00f8rnland, K. et al. Partial biliary diversion may promote long term relief of pruritus and native liver survival in children with cholestatic liver diseases. Eur. J. Pediatr. Surg. https:\/\/doi.org\/10.1055\/s-0040-1714657 (2020).","DOI":"10.1055\/s-0040-1714657"},{"key":"1153_CR25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11103-012-9885-2","volume":"80","author":"F Xie","year":"2012","unstructured":"Xie, F., Xiao, P., Chen, D., Xu, L. & Baohong, Z. miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs. Plant Mol. Biol. 80, 75\u201384 (2012).","journal-title":"Plant Mol. Biol."},{"key":"1153_CR26","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","volume":"64","author":"CL Andersen","year":"2004","unstructured":"Andersen, C. L., Jensen, J. L. & \u00d8rntoft, T. F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 64, 5245\u20135250 (2004).","journal-title":"Cancer Res."},{"key":"1153_CR27","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele, J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, research0034 (2002).","journal-title":"Genome Biol."},{"key":"1153_CR28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1023\/B:BILE.0000019559.84305.47","volume":"26","author":"MW Pfaffl","year":"2004","unstructured":"Pfaffl, M. W., Tichopad, A., Prgomet, C. & Neuvians, T. P. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol. Lett. 26, 509\u2013515 (2004).","journal-title":"Biotechnol. Lett."},{"key":"1153_CR29","volume":"11","author":"DC Muth","year":"2018","unstructured":"Muth, D. C., Powell, B. H., Zhao, Z. & Witwer, K. W. miRNAs in platelet-poor blood plasma and purified RNA are highly stable: a confirmatory study. BMC Res. Notes 11, 273 (2018).","journal-title":"BMC Res. Notes"},{"key":"1153_CR30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0969141315593571","volume":"23","author":"AJ Lawson","year":"2016","unstructured":"Lawson, A. J., Bernstone, L. & Hall, S. K. Newborn screening blood spots analysis in the UK: influence of spot size, punch location and hematocrit. J. Med. Screen. 23, 7\u201316 (2016).","journal-title":"J. Med. Screen."},{"key":"1153_CR31","doi-asserted-by":"crossref","first-page":"e20769","DOI":"10.1371\/journal.pone.0020769","volume":"6","author":"R Duttagupta","year":"2011","unstructured":"Duttagupta, R., Jiang, R., Gollub, J. & Jones, K. W. Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS ONE 6, e20769 (2011).","journal-title":"PLoS ONE"},{"key":"1153_CR32","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-15-474","volume":"15","author":"P Leidinger","year":"2014","unstructured":"Leidinger, P., Backes, C., Meder, B., Meese, E. & Keller, A. The human miRNA repertoire of different blood compounds. BMC Genomics 15, 474 (2014).","journal-title":"BMC Genomics"},{"key":"1153_CR33","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1093\/nar\/gkx706","volume":"45","author":"S Juzenas","year":"2017","unstructured":"Juzenas, S. et al. A comprehensive, cell specific microRNA catalogue of human peripheral blood. Nucleic Acids Res. 45, 9290\u20139301 (2017).","journal-title":"Nucleic Acids Res."},{"key":"1153_CR34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jaut.2009.02.022","volume":"32","author":"KA Padgett","year":"2009","unstructured":"Padgett, K. A. et al. Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J. Autoimmun. 32, 246\u2013253 (2009).","journal-title":"J. Autoimmun."},{"key":"1153_CR35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.lfs.2016.04.034","volume":"155","author":"M Wen","year":"2016","unstructured":"Wen, M., Men, R., Liu, X. & Li, Y. Involvement of miR-30c in hepatic stellate cell activation through the repression of plasminogen activator inhibitor-1. Life Sci. 155, 21\u201328 (2016).","journal-title":"Life Sci."},{"key":"1153_CR36","first-page":"5188","volume":"18","author":"H Zhang","year":"2012","unstructured":"Zhang, H. et al. Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B. World J. Gastroenterol. 18, 5188\u20135196 (2012).","journal-title":"World J. Gastroenterol."},{"key":"1153_CR37","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s12072-019-09993-w","volume":"13","author":"S Ren","year":"2019","unstructured":"Ren, S. et al. MicroRNA-744\/transforming growth factor \u03b21 relationship regulates liver cirrhosis. Hepatol. Int. 13, 814\u2013825 (2019).","journal-title":"Hepatol. Int."},{"key":"1153_CR38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.clinre.2014.09.010","volume":"39","author":"YL Tan","year":"2015","unstructured":"Tan, Y. L. et al. miR-744 is a potential prognostic marker in patients with hepatocellular carcinoma. Clin. Res. Hepatol. Gastroenterol. 39, 359\u2013365 (2015).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"1153_CR39","doi-asserted-by":"crossref","first-page":"e32999","DOI":"10.1371\/journal.pone.0032999","volume":"7","author":"C Roderburg","year":"2012","unstructured":"Roderburg, C. et al. Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis. PLoS ONE 7, e32999 (2012).","journal-title":"PLoS ONE"},{"key":"1153_CR40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1247\/csf.17005","volume":"42","author":"J Xuan","year":"2017","unstructured":"Xuan, J. et al. MiR-29a and miR-652 attenuate liver fibrosis by inhibit the differentiation of CD4+ T cells. Cell Struct. Funct. 42, 95\u2013103 (2017).","journal-title":"Cell Struct. Funct."},{"key":"1153_CR41","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1373\/clinchem.2007.088344","volume":"53","author":"P Carraro","year":"2007","unstructured":"Carraro, P. & Plebani, M. Errors in a stat laboratory: types and frequencies 10 years later. Clin. Chem. 53, 1338\u20131342 (2007).","journal-title":"Clin. Chem."},{"key":"1153_CR42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.21037\/atm.2018.04.02","volume":"6","author":"G Lippi","year":"2018","unstructured":"Lippi, G. & Plebani, M. A six-sigma approach for comparing diagnostic errors in healthcare-where does laboratory medicine stand? Ann. Transl. Med. 6, 180 (2018).","journal-title":"Ann. Transl. Med."},{"key":"1153_CR43","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2144\/03356bm03","volume":"35","author":"ML Johnson","year":"2003","unstructured":"Johnson, M. L., Navanukraw, C., Grazul-Bilska, A. T., Reynolds, L. P. & Redmer, D. A. Heparinase treatment of RNA before quantitative real time RT-PCR. Biotechniques 35, 1140\u20131142 (2003).","journal-title":"Biotechniques"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01153-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01153-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01153-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T23:17:56Z","timestamp":1631661476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01153-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1153"],"URL":"https:\/\/doi.org\/10.1038\/s41390-020-01153-3","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]},"assertion":[{"value":"14 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from participants or parents\/caregivers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}}]}}